Literature DB >> 15814849

Transcriptional regulation by steroid receptor coactivator phosphorylation.

Ray-Chang Wu1, Carolyn L Smith, Bert W O'Malley.   

Abstract

The basic mechanisms underlying ligand-dependent transcriptional activation by nuclear receptors (NRs) require the sequential recruitment of various coactivators. Increasing numbers of coactivators have been identified in recent years, and both biochemical and genetic studies demonstrate that these coactivators are differentially used by transcription factors, including NRs, in a cell/tissue type- and promoter-specific manner. However, the molecular basis underlying this specificity remains largely unknown. Recently, NRs and coregulators were shown to be targets of posttranslational modifications activated by diverse cellular signaling pathways. It is argued that posttranslational modifications of these proteins provide the basis for a combinatorial code required for specific gene activation by NRs and coactivators, and that this code also enables coactivators to efficiently stimulate the activity of other classes of transcription factors. In this review, we will focus on coactivators and discuss the recent progress in understanding the role of phosphorylation of the steroid receptor coactivator family and the potential ramifications of this posttranslational modification for regulation of gene expression.

Mesh:

Substances:

Year:  2005        PMID: 15814849     DOI: 10.1210/er.2004-0018

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  48 in total

Review 1.  Myelin disorders: Causes and perspectives of Charcot-Marie-Tooth neuropathy.

Authors:  Gerd Meyer zu Hörste; Thomas Prukop; Klaus-Armin Nave; Michael W Sereda
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 2.  Influence of berry polyphenols on receptor signaling and cell-death pathways: implications for breast cancer prevention.

Authors:  Harini S Aiyer; Anni M Warri; Denzel R Woode; Leena Hilakivi-Clarke; Robert Clarke
Journal:  J Agric Food Chem       Date:  2012-02-22       Impact factor: 5.279

Review 3.  Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity.

Authors:  Nicole L Moore; Ramesh Narayanan; Nancy L Weigel
Journal:  Steroids       Date:  2007-01-04       Impact factor: 2.668

4.  Estrogen receptor β (ERβ1) transactivation is differentially modulated by the transcriptional coregulator Tip60 in a cis-acting element-dependent manner.

Authors:  Ming-Tsung Lee; Yuet-Kin Leung; Irving Chung; Pheruza Tarapore; Shuk-Mei Ho
Journal:  J Biol Chem       Date:  2013-07-15       Impact factor: 5.157

5.  Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells.

Authors:  Aarti D Rohira; Fei Yan; Lei Wang; Jin Wang; Suoling Zhou; Andrew Lu; Yang Yu; Jianming Xu; David M Lonard; Bert W O'Malley
Journal:  Cancer Res       Date:  2017-06-13       Impact factor: 12.701

Review 6.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

7.  Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression.

Authors:  Lisa M Arendt; Tara L Grafwallner-Huseth; Linda A Schuler
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

8.  Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.

Authors:  Jian-Hua Zhou; David V Yu; Jingwei Cheng; David J Shapiro
Journal:  Steroids       Date:  2007-07-07       Impact factor: 2.668

9.  SIP, a novel ankyrin repeat containing protein, sequesters steroid receptor coactivators in the cytoplasm.

Authors:  Ying Zhang; Hua Zhang; Jing Liang; Wenhua Yu; Yongfeng Shang
Journal:  EMBO J       Date:  2007-05-03       Impact factor: 11.598

10.  The role of AIB1 in breast cancer.

Authors:  Alan K Chang; Huijian Wu
Journal:  Oncol Lett       Date:  2012-07-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.